Literature DB >> 9477125

Stem cell factor, the JAK-STAT pathway and signal transduction.

D Linnekin1, S Mou, C S Deberry, S R Weiler, J R Keller, F W Ruscetti, D L Longo.   

Abstract

Recent work has demonstrated the importance of Janus family kinases (JAKs) and signal transducers and activators of transcription (STATs) in the stimulus-response coupling of receptors lacking intrinsic tyrosine kinase activity. In particular, the JAK-STAT pathway appears critical in signal transduction by interferon as well as numerous hematopoietic growth factors interacting with members of the hemapoietin receptor superfamily. Although ligands that interact with receptor tyrosine kinases (RTK), such as epidermal growth factor (EGF), platelet-derived growth factor (PDGF) and colony stimulating factor-1 (CSF-1), have been shown to induce increases in phosphorylation of both JAKs and STATs, little is known about activation of this pathway by stem cell factor (SCF). This review will summarize what is known about the JAK/STAT pathway in relation to SCF signal transduction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9477125     DOI: 10.3109/10428199709058310

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  13 in total

1.  Differences in lymphocyte developmental potential between human embryonic stem cell and umbilical cord blood-derived hematopoietic progenitor cells.

Authors:  Colin H Martin; Petter S Woll; Zhenya Ni; Juan Carlos Zúñiga-Pflücker; Dan S Kaufman
Journal:  Blood       Date:  2008-07-11       Impact factor: 22.113

2.  Activation of Wnt signaling in cKit-ITD mediated transformation and imatinib sensitivity in acute myeloid leukemia.

Authors:  Lara Tickenbrock; Sina Hehn; Bülent Sargin; Georg Evers; Pavankumar Reddy Ng; Chunaram Choudhary; Wolfgang E Berdel; Carsten Müller-Tidow; Hubert Serve
Journal:  Int J Hematol       Date:  2008-07-31       Impact factor: 2.490

Review 3.  Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.

Authors:  Jing Wu; Ji Chen; Zhi-Qing Tian; Hao Zhang; Ruo-Lan Gong; Tong-Xin Chen; Li Hong
Journal:  J Clin Immunol       Date:  2017-02-14       Impact factor: 8.317

Review 4.  Growth factors improve neurogenesis and outcome after focal cerebral ischemia.

Authors:  Ronen Robert Leker; Valeri Lasri; David Chernoguz
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

Review 5.  Regulation of monocyte differentiation by specific signaling modules and associated transcription factor networks.

Authors:  René Huber; Daniel Pietsch; Johannes Günther; Bastian Welz; Nico Vogt; Korbinian Brand
Journal:  Cell Mol Life Sci       Date:  2013-03-24       Impact factor: 9.261

6.  The stem cell factor (SCF)/c-KIT signalling in testis and prostate cancer.

Authors:  Henrique J Cardoso; Marília I Figueira; Sílvia Socorro
Journal:  J Cell Commun Signal       Date:  2017-06-27       Impact factor: 5.782

7.  TGF-beta cooperates with TGF-alpha to induce the self-renewal of normal erythrocytic progenitors: evidence for an autocrine mechanism.

Authors:  O Gandrillon; U Schmidt; H Beug; J Samarut
Journal:  EMBO J       Date:  1999-05-17       Impact factor: 11.598

Review 8.  Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.

Authors:  Peyman Ranji; Tayyebali Salmani Kesejini; Sara Saeedikhoo; Ali Mohammad Alizadeh
Journal:  Tumour Biol       Date:  2016-08-26

9.  Primordial germ cells and gastrointestinal stromal tumors respond distinctly to a cKit overactivating allele.

Authors:  Li Chen; Mehlika Faire; Michael D Kissner; Diana J Laird
Journal:  Hum Mol Genet       Date:  2012-10-16       Impact factor: 6.150

10.  Essential role of signal transducer and activator of transcription (Stat)5a but not Stat5b for Flt3-dependent signaling.

Authors:  S Zhang; S Fukuda; Y Lee; G Hangoc; S Cooper; R Spolski; W J Leonard; H E Broxmeyer
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.